Ketamine Completed Phase 0 Trials for Depression Prevention

IndicationsStatusPurposePhase
CompletedPrevention0
clinicaltrials.gov IdentifierTitleDrugs
NCT02414932Ketamine for Depression Relapse Prevention Following ECT